Brazil biomedical center says shipment of Chinese vaccine ingredients delayed

Health News

BRASILIA (Reuters) – The head of Brazilian biomedical center Butantan said on Wednesday that China would not clear a cargo of active ingredients to produce Sinovac’s COVID-19 vaccine for shipment to Brazil by May 13, as previously expected.

Butantan Director Dimas Covas said there was no clear date for when Chinese authorities would approve the shipment. Butantan is producing the Coronavac vaccine domestically in partnership with Sinovac.

Source: Read Full Article

Related posts:
  1. Brazil to vaccinate entire population for COVID-19 in 2021, health minister says
  2. Brazil registers 85,663 new coronavirus cases and 2,216 new COVID-19 deaths-health ministry
  3. No virus variants can evade all antibody types, so far; new variants can infect mice
  4. WHO official says Wuhan probe does not dramatically change picture of outbreak
  5. Eli Lilly's antibody combination receives FDA emergency use authorization for COVID-19